These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 8105825

  • 21. [Recent research trends in diagnosis, treatment, and prevention of drug-induced extrapyramidal symptoms seen in psychiatric patients].
    Inada T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Oct; 16(5):181-5. PubMed ID: 8962437
    [Abstract] [Full Text] [Related]

  • 22. What may be gained from neuropsychological investigations of tardive dyskinesia?
    Cohen H, Cohen D.
    Brain Cogn; 1993 Sep; 23(1):1-7. PubMed ID: 8105818
    [Abstract] [Full Text] [Related]

  • 23. Movement disorders in patients treated with long-acting injectable antipsychotic drugs.
    Bransgrove LL, Kelly MW.
    Am J Hosp Pharm; 1994 Apr 01; 51(7):895-9. PubMed ID: 7912473
    [Abstract] [Full Text] [Related]

  • 24. [Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital].
    Bourgeois M.
    Encephale; 1977 Apr 01; 3(4):299-320. PubMed ID: 611013
    [Abstract] [Full Text] [Related]

  • 25. Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes.
    Dose M.
    Pharmacopsychiatry; 2000 Sep 01; 33 Suppl 1():3-13. PubMed ID: 11072761
    [Abstract] [Full Text] [Related]

  • 26. Parallels between neuroleptic effects and lethargic encephalitis: the production of dyskinesias and cognitive disorders.
    Breggin PR.
    Brain Cogn; 1993 Sep 01; 23(1):8-27. PubMed ID: 8105824
    [Abstract] [Full Text] [Related]

  • 27. Diabetes is not a risk factor for tardive dyskinesia: a retrospective observational study.
    Raja M, Azzoni A.
    Hum Psychopharmacol; 2002 Jan 01; 17(1):61-3. PubMed ID: 12404708
    [Abstract] [Full Text] [Related]

  • 28. Affective disorders and tardive dyskinesia.
    Casey DE.
    Encephale; 1988 Sep 01; 14 Spec No():221-6. PubMed ID: 2905650
    [Abstract] [Full Text] [Related]

  • 29. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia.
    Damier P, Thobois S, Witjas T, Cuny E, Derost P, Raoul S, Mertens P, Peragut JC, Lemaire JJ, Burbaud P, Nguyen JM, Llorca PM, Rascol O, French Stimulation for Tardive Dyskinesia (STARDYS) Study Group.
    Arch Gen Psychiatry; 2007 Feb 01; 64(2):170-6. PubMed ID: 17283284
    [Abstract] [Full Text] [Related]

  • 30. Tardive dyskinesia: prevalence, incidence, and risk factors.
    Kane JM, Woerner M, Lieberman J.
    J Clin Psychopharmacol; 1988 Aug 01; 8(4 Suppl):52S-56S. PubMed ID: 3065365
    [Abstract] [Full Text] [Related]

  • 31. Handedness and the risk of tardive dyskinesia.
    Morgenstern H, Glazer WM, Doucette JT.
    Biol Psychiatry; 1996 Jul 01; 40(1):35-42. PubMed ID: 8780853
    [Abstract] [Full Text] [Related]

  • 32. Prevalence of tardive dyskinesia in affective disorder patients.
    Yassa R, Ghadirian AM, Schwartz G.
    J Clin Psychiatry; 1983 Nov 01; 44(11):410-2. PubMed ID: 6139365
    [Abstract] [Full Text] [Related]

  • 33. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y, Fan CH, Deng HH, Hu SH, Lv DP, Li LH, Wang JJ, Lu XQ.
    Acta Pharmacol Sin; 2006 Mar 01; 27(3):328-32. PubMed ID: 16490169
    [Abstract] [Full Text] [Related]

  • 34. An electroencephalographic study of psychiatric inpatients with antipsychotic-induced tardive dyskinesia.
    Koshino Y, Hiramatsu H, Isaki K, Yamaguchi N.
    Clin Electroencephalogr; 1986 Jan 01; 17(1):30-5. PubMed ID: 2869843
    [Abstract] [Full Text] [Related]

  • 35. Tardive dyskinesia: determinants of temporal dynamics of its emergence.
    Latalova K.
    Neuro Endocrinol Lett; 2008 Dec 01; 29(6):995-8. PubMed ID: 19112392
    [Abstract] [Full Text] [Related]

  • 36. Neuroleptic medication facilitates the natural occurrence of tardive dyskinesia. A critical review.
    Driesens F.
    Acta Psychiatr Belg; 1988 Dec 01; 88(3):195-205. PubMed ID: 2906780
    [Abstract] [Full Text] [Related]

  • 37. The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics.
    Spohn HE, Coyne L.
    Brain Cogn; 1993 Sep 01; 23(1):28-39. PubMed ID: 8105820
    [Abstract] [Full Text] [Related]

  • 38. [Epidemiology of tardive dyskinesias in the Maghreb].
    Moussaoui D, Douki S, Bentounsi B, Otarid A, Chorfi M, Mamou A, Benamor L.
    Encephale; 1988 Sep 01; 14 Spec No():203-8. PubMed ID: 2905647
    [Abstract] [Full Text] [Related]

  • 39. [Neuroleptic medication and the risk of tardive dyskinesia: a survey of psychiatrists and general practitioners in Quebec].
    Cohen D, Bisson J.
    Sante Ment Que; 1997 Sep 01; 22(1):263-82. PubMed ID: 9233282
    [Abstract] [Full Text] [Related]

  • 40. [Lack of involuntary abnormal movements in untreated schizophrenic patients].
    Hernán Silva I, Jerez CS, Ruiz TA, Seguel LM, Court LJ, Labarca BR.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1994 Sep 01; 22(5):200-2. PubMed ID: 7817846
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.